• Sopharma shareholders approved a shareholder-proposed gross dividend for 2026 of EUR 0.068 per share at the October 30, 2026 annual general meeting.
• Shareholders rejected the board’s dividend proposal. The annual financial report was adopted.
• The ex-dividend date is November 12, 2026; the dividend record date is November 13, 2026.
• Dividend payments are scheduled to begin November 27, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sopharma AD published the original content used to generate this news brief on October 30, 2026, and is solely responsible for the information contained therein.